Pharmafile Logo

Research Partnership’s MedTech Division appoints two Directors

May 14, 2021 | Medtech, News, Staff announcement 

Chris Carles has joined as a Director in our Philadelphia office and Andrew Way as a Research Director in our UK office.

We are delighted to announce that Chris Carles has joined as a Director in our Philadelphia office and Andrew Way as a Research Director in our UK office.

Chris has over 27 years’ experience in healthcare research and consulting and his peers acknowledge him to be a strategic thinker with a demonstrated ability to leverage primary and secondary market research, connecting disparate pieces of information to form a clear picture. He most recently served as Vice President, Strategic Research Services for the KJT Group and his other professional experiences include roles with a product design consultancy, independent moderating, Becton Dickinson and with J&J’s Ethicon Endo-Surgery.

Andrew is a seasoned market research professional with over 13 years’ experience in healthcare research and consulting. He has experience of working across a broad range of therapy areas and devices and has previously focused on both quantitative and qualitative research. Andrew has previously worked at InStar Research and Medex Research.

Head of MedTech Division, Sabera Hyderally said of the appointment, “I am delighted to welcome both Chris and Andrew to the MedTech division. They bring a wealth of experience, deep knowledge and fresh ideas and I’m excited to partner with researchers of their calibre as we continue our tremendous growth globally.”

Founding Director Mary Assimakopoulos added, “We are very pleased that both Chris and Andrew have chosen to join Research Partnership. They have both previously worked with a range of MedTech clients and bring a great depth of experience to the team, which aims to stay at the forefront of best practice and innovation.”

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Eyeforpharma Real World Evidence Conference Round up 2018

Earlier this month, APAC Director Pei Li Teh attended Asia’s 11th Eyeforpharma conference in Tokyo, Japan with a focus on Real World Evidence (RWE)This year has seen a turning point...

EphMRA Annual Conference 2018

Visit us on stand number 20

Connected Patients – Adopting a patient-centric approach in emerging markets

The concept of patient centricity and putting the patient at the heart of care is being widely adopted by the healthcare industry – the general consensus being that it’s going...

Combination therapies in oncology: The benefits of integrated insights

14 June 2018 11am EDT | 8am PDT | 4pm BST | 5pm CE

Intellus round up 2018

Earlier this month, US President Harriet Kozak and Emerging Markets Director Rachel Howard attended the inaugural Intellus Worldwide Summit in Philadelphia

Janssen & Research Partnership win prestigious BHBIA Best Business Impact award

We are delighted to announce that Janssen and Research Partnership have won the BOBI (Best of Business Intelligence) Award in the Best Business Impact category at the BHBIA annual conference in London for our collaborative market research...

How published research underpinned a cancer therapy awareness campaign

Our client markets a product for Oral Mucositis (OM) - a side effect of cancer treatment - and wanted to better understand the disease and treatment challenges faced by both...

How integrated insights supported a biologic launch strategy across multiple indications

Our client is launching a new biologic in dermatology across indications and needed to understand the market, including the patient pool, treatment landscape, potential uptake and pricing opportunity for their...

How a hybrid approach delivered fast insights to feed into an oncology product’s adoption strategy

Our client wanted to quantify how ovarian cancer patients are managed prior to product launch, but also needed to understand why patients do or do not receive key diagnostic tests...